Back to Search Start Over

High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis.

Authors :
Simpson-Yap, Steve
Oddy, Wendy H
Taylor, Bruce
Lucas, Robyn M
Black, Lucinda J
Ponsonby, Anne-Louise
Blizzard, Leigh
van der Mei, Ingrid
Dear, Keith
Dwyer, Terry
Taylor, Bruce V
Broadley, Simon
Kilpatrick, Trevor
Williams, David
Lechner-Scott, Jeanette
Shaw, Cameron
Chapman, Caron
Coulthard, Alan
Pender, Michael P
Valery, Patricia
Source :
Multiple Sclerosis Journal. Jun2021, Vol. 27 Issue 7, p1112-1124. 13p.
Publication Year :
2021

Abstract

Background: Dietary patterns and their association with subsequent clinical course have not been well studied in early multiple sclerosis (MS). Objectives: To describe dietary patterns in people in 5 years following first clinical demyelination and assess associations with MS conversion and relapse. Methods: This study included baseline food frequency questionnaire dietary intake (entry to the Ausimmune Study) and 5-year follow-up; iterated principal factor analysis was applied. MS conversion and relapse risks were assessed by Cox proportional hazards models, adjusted for age, sex, study site, education, body mass index (BMI), smoking and omega-3 supplement use. Results: In cases with a first clinical diagnosis of central nervous system (CNS) demyelination, we identified three major dietary patterns, 'Prudent', 'High-Vegetable' and 'Mixed', explaining 43%, 37% and 24% of diet variance in dietary intake, respectively. Fruits, vegetables, fish, wholegrains and nuts loaded highly on the Prudent pattern, starchy vegetables and legumes on the High-Vegetable pattern, and meats and alcohol on the Mixed pattern. Diet factor scores were not associated with MS conversion risk. Those with baseline Prudent scores above the median had significantly lower relapse risk (adjusted hazard ratio = 0.54, 95% confidence interval (CI) 0.37, 0.81) with some evidence of a plateau effect. Conclusion: Prudent diet factor score above the median was prospectively associated with lower relapse risk in the 5 years following the first clinical demyelinating event. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13524585
Volume :
27
Issue :
7
Database :
Academic Search Index
Journal :
Multiple Sclerosis Journal
Publication Type :
Academic Journal
Accession number :
150449748
Full Text :
https://doi.org/10.1177/1352458520943087